skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.12d (Release date: 2017-12-26)
SearchBox Top
SearchBox Bottom
NY-ESO-1b Peptide Vaccine (Code C68999)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: NY-ESO-1b Peptide Vaccine

Definition: A recombinant nonapeptide used as an antineoplastic vaccine. NY-ESO-1b peptide vaccine contains the amino acid sequence SLLMWITQC, derived from the cancer-testis tumor antigen (NY-ESO-1), which is expressed on tumor cells of many different types, including melanomas. Vaccination with this peptide vaccine may elicit strong humoral and cellular immune responses to NY-ESO-1-expressing cancers.

Label: NY-ESO-1b Peptide Vaccine

NCI Thesaurus Code: C68999 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: CL371861  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
NY-ESO-1b Peptide (p157-165)
NY-ESO-1b Peptide Vaccine

External Source Codes: 
PDQ Closed Trial Search ID 544199
PDQ Open Trial Search ID 544199 (check for NCI PDQ open clinical trial info)

Other Properties:
     Name Value (qualifiers indented underneath)
code C68999
Legacy_Concept_Name NY-ESO-1b_Peptide_Vaccine
Semantic_Type Immunologic Factor
Semantic_Type Pharmacologic Substance

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom